DK70385A - Bakteriepraeparat og fremgangsmaade til fremstilling deraf - Google Patents

Bakteriepraeparat og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK70385A
DK70385A DK70385A DK70385A DK70385A DK 70385 A DK70385 A DK 70385A DK 70385 A DK70385 A DK 70385A DK 70385 A DK70385 A DK 70385A DK 70385 A DK70385 A DK 70385A
Authority
DK
Denmark
Prior art keywords
preparing
procedure
bakery
preparation
bakery preparation
Prior art date
Application number
DK70385A
Other languages
Danish (da)
English (en)
Other versions
DK70385D0 (da
Inventor
Antti Robert Mikkola
Heli-Riitta Marjaana Hakkinen
Lasse Olavi Nuotio
Esko Viljo Nurmi
Carita Elisabeth Schneitz
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DK70385D0 publication Critical patent/DK70385D0/da
Publication of DK70385A publication Critical patent/DK70385A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
DK70385A 1984-03-01 1985-02-15 Bakteriepraeparat og fremgangsmaade til fremstilling deraf DK70385A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI840816A FI840816A0 (fi) 1984-03-01 1984-03-01 Bakteriepreparat

Publications (2)

Publication Number Publication Date
DK70385D0 DK70385D0 (da) 1985-02-15
DK70385A true DK70385A (da) 1985-09-02

Family

ID=8518638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK70385A DK70385A (da) 1984-03-01 1985-02-15 Bakteriepraeparat og fremgangsmaade til fremstilling deraf

Country Status (10)

Country Link
US (1) US4657762A (de)
EP (1) EP0154478A3 (de)
JP (1) JPH0759516B2 (de)
AU (1) AU581198B2 (de)
CA (1) CA1236400A (de)
DK (1) DK70385A (de)
ES (1) ES8605375A1 (de)
FI (1) FI840816A0 (de)
NO (1) NO165744C (de)
ZA (1) ZA85324B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910024A (en) * 1988-07-05 1990-03-20 Micro Chemical, Inc. Method and apparatus for administering live bacteria as feed additives to livestock and poultry
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
EP0433299B1 (de) * 1988-08-02 1998-05-06 Gastro Services Pty. Limited (ACN 002 994 890) Behandlung von gastro-intestinalen krankheiten
US5206015A (en) * 1989-06-05 1993-04-27 The United States Of America As Represented By The Secretary Of Agriculture Introduction of bacteria in ovo
GB2233343B (en) * 1989-06-30 1993-07-07 Farmos Oy A bacterial preparation for use in poultry
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5302388A (en) * 1991-11-13 1994-04-12 Wisconsin Alumni Research Foundation Control of campylobacter jejuni colonization
EP0689381B1 (de) * 1993-03-16 2000-01-05 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF AGRICULTURE Kompetitiv verdrängende schleimhautflora
EP0801675B1 (de) * 1994-07-29 2003-04-16 The United States of America, as Represented by the Secretary, Department of Agriculture Saccharomyces-behandlung zur verringerung von campylobakter- und salmonella-populationen in geflügel
US5722342A (en) * 1996-06-28 1998-03-03 Us Agriculure Ovo antibiotic and microbial treatment to dimenish salmonellae populations in avians
US5807546A (en) 1996-10-11 1998-09-15 The United States Of America As Represented By The Secretary Of Agriculture Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
AT407008B (de) * 1998-08-06 2000-11-27 Viernstein Helmut Dr Formulierungen mit probiotisch wirksamen mikroorganismen
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20040241150A1 (en) * 2002-12-19 2004-12-02 Hargis Billy M. Defined competitive exclusion cultures for food borne pathogens
EP2359836A1 (de) 2005-03-18 2011-08-24 The United States of America as represented by the secretary of Agriculture Bakteriocine und neue Bakterienstämme
EP2351494A1 (de) 2005-03-18 2011-08-03 The United States of America as represented by the secretary of Agriculture Bakteriocine und neue Bakterienstämme
US9005601B2 (en) 2010-07-16 2015-04-14 The Board Of Trustees Of The University Of Arkansas Methods and compositions including spore-forming bacteria for increasing the health of animals
NZ618935A (en) 2010-08-04 2014-03-28 Karma Medical Prod Co Ltd Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
US9107938B2 (en) 2010-09-30 2015-08-18 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
BR112013022927A2 (pt) 2011-03-09 2016-12-06 Univ Minnesota composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
WO2014022572A1 (en) 2012-08-01 2014-02-06 Pacific Vet Group-Usa, Inc. Probiotic for amelioration of coccidiosis vaccine reaction
AU2014283182B9 (en) * 2013-06-20 2018-01-04 Mars, Incorporated Performance pet food product
WO2016183577A1 (en) 2015-05-14 2016-11-17 Crestovo Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
ES2909456T3 (es) 2015-05-22 2022-05-06 Univ Arizona State Métodos para tratar el trastorno del espectro autista y síntomas asociados
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
US11433102B2 (en) 2017-04-05 2022-09-06 Finch Therapeutics Holdings Llc Compositions and methods for treating Parkinson's disease (PD) and related disorders
JP2020521760A (ja) 2017-05-26 2020-07-27 クレストヴォ・ホールディングス・エルエルシー 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
US11911419B2 (en) 2018-09-27 2024-02-27 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953609A (en) * 1974-02-06 1976-04-27 Microlife Technics, Inc. Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628
US4030978A (en) * 1976-07-29 1977-06-21 Becton, Dickinson And Company Novel assembly, compositions and methods
JPS54143585A (en) * 1978-04-28 1979-11-08 Kyowa Hakko Kogyo Co Ltd Culturing of microbials and storing of freeze-dried microbial cells
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
US4251509A (en) * 1980-01-31 1981-02-17 Wisconsin Alumni Research Foundation Dry particulate vaccine for oral administration

Also Published As

Publication number Publication date
EP0154478A2 (de) 1985-09-11
CA1236400A (en) 1988-05-10
ZA85324B (en) 1985-08-28
EP0154478A3 (de) 1987-06-10
FI840816A0 (fi) 1984-03-01
NO165744C (no) 1991-04-10
ES540375A0 (es) 1986-03-16
AU581198B2 (en) 1989-02-16
DK70385D0 (da) 1985-02-15
NO165744B (no) 1990-12-27
JPH0759516B2 (ja) 1995-06-28
JPS60202823A (ja) 1985-10-14
US4657762A (en) 1987-04-14
NO850817L (no) 1985-09-02
ES8605375A1 (es) 1986-03-16
AU3758085A (en) 1985-09-05

Similar Documents

Publication Publication Date Title
DK70385A (da) Bakteriepraeparat og fremgangsmaade til fremstilling deraf
DK158562C (da) Diffusionsovertrukket polydepotpraeparat og fremgangsmaade til fremstilling deraf
DK325982A (da) Findelt inhalationspraeparat og fremgangsmaade til fremstillingheraf
DK163951C (da) Antibakterielt foderpraeparat og fremgangsmaade til fremstilling deraf
DK554685D0 (da) Renininhiberende dipeptider og fremgangsmaade til fremstilling deraf
DK256485A (da) Veterinaert praeparat og fremgangsmaade til fremstilling deraf
DK51286A (da) Desoxyadenosinphosphatforbindelser og fremgangsmaade til fremstilling afdisse
DK446982A (da) Cyanosteroider og fremgangsmaade til deres fremstilling
DK118585D0 (da) Mundskyllepraeparat og fremgangsmaade til fremstilling deraf
DK315085A (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK355387A (da) Overtraekspraeparat og fremgangsmaade til anvendelse deraf
DK375085D0 (da) Quinolon-carboxylsyre-derivater og fremgangsmaade til fremstilling deraf
DK58882A (da) Katalysator-forstadium til oxychlorering og fremgangsmaade til fremstilling heraf
DK313785A (da) Dihydroorotsyrederivat og fremgangsmaade til fremstilling deraf
DK362987A (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK401385D0 (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK358385A (da) Tyggegummiblandinger og fremgangsmaade til deres fremstilling
DK372582A (da) Immunogent kompleks og fremgangsmaade til fremstilling deraf
NO851687L (no) Kryssbundne karboksyl-polyelektrolytter og fremgangsmaate for deres fremstilling
DK446685A (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK163028C (da) Stabiliseret anthralinpraeparat og fremgangsmaade til fremstilling deraf
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK292685D0 (da) Thiazolidinderivater og fremgangsmaader til fremstilling deraf
DK552284A (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK471783A (da) Farmaceutisk praeparat og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment